Can your immune system predict a c. diff relapse?
NCT ID NCT02440438
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how the immune system responds to Clostridium difficile infection in hospitalized patients. Researchers took blood samples every two days to measure immune markers. The goal was to find out why some patients have repeat infections. The study involved 56 participants and was completed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help identify which patients are at higher risk of relapse, leading to better monitoring or tailored treatments.
- What could go wrong
- This is an observational study with only 56 participants, so findings may not apply to all patients. Results are preliminary and need confirmation in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIARRHEA DUE TO CLOSTRIDIUM DIFFICILE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service d'Hygiène, Epidémiologie et Prévention - Hôpital Edouard Herriot
Lyon, 69437, France